Skip to main content
Clinical Trials/EUCTR2007-006268-32-IT
EUCTR2007-006268-32-IT
Active, not recruiting
Not Applicable

EFFICACY AND SAFETYOF BOTULINUM TOXIN THERAPY ON UPPER LIMB SPASTICITY IN INFLAMMATORY AND DEMIELINIZZATING DISEASE OF CENTRAL NERVOUS SYSTEM. - ND

OSPEDALE S. RAFFAELE0 sitesNovember 23, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
multiple sclerosis
Sponsor
OSPEDALE S. RAFFAELE
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 23, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
OSPEDALE S. RAFFAELE

Eligibility Criteria

Inclusion Criteria

  • patients aged more then 18 affected by primary or secondary progressive SM or by other chronic inflammatory diseases of the CNS diagnosed 6 months before the beginning of the study;arm spasticity with 1 or more point for Modified Ashworth Scale ; ...........
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • permanent contractures or severe atrophy in spastic arm; previous treatment with BT\-A or with alccol/phenol injection or surgery;modification in madical therapy or rehabilitation therapy in the prevoious 3 months; treatment with intratecal baclofen or with drugs modulationg neuromuscolar trasmission; .......

Outcomes

Primary Outcomes

Not specified

Similar Trials